KASPI.KZ ANNOUNCES CLOSING OF UPSIZED U.S. INITIAL PUBLIC OFFERING
ALMATY, KAZAKHSTAN / ACCESSWIRE / January 23, 2024 / Joint Stock Company Kaspi.kz (the "Company" or "Kaspi.kz") (NASDAQ:KSPI) today announces the closing of the upsized U.S. initial public offering (the "Offering") of 11,300,000 American depositary shares ("ADSs"), each representing one of the Company’s common shares, sold by Mr. Vyacheslav Kim, Mr. Mikheil Lomtadze and Asia Equity Partners Limited (the "Selling Shareholders") at a public offering price of $92.00 per ADS. The ADSs began trading on the Nasdaq Global Select Market on January 19, 2024 under the symbol "KSPI."
Morgan Stanley, J.P. Morgan and Citigroup acted as lead active bookrunners for the Offering, and Susquehanna Financial Group, LLLP and Wolfe | Nomura Alliance acted as additional bookrunning managers for the Offering.
The Offering was made only by means of a prospectus. Copies of the final prospectus relating to the Offering may be obtained by visiting EDGAR on the website of the U.S. Securities and Exchange Commission at www.sec.gov. Alternatively, copies of the final prospectus may be obtained from:
· Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; tel.: +1 866 718 1649; email: prospectus@morganstanley.com;
· J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717; tel.: +1 866 803 9204; and
· Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717; tel.: +1 800 831 9146.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the U.S. Securities Act of 1933, as amended.
About Kaspi.kz
Kaspi.kz operates a two-sided Super App business model: the Kaspi.kz Super App for consumers and the Kaspi Pay Super App for merchants and entrepreneurs. Kaspi.kz’s offerings include payments, marketplace and fintech solutions for both consumers and merchants.
This announcement is not for distribution in any jurisdiction where its publication, distribution or release would be unlawful.
This announcement and any offer of securities to which it relates is only addressed to and directed at (a) in any Member State of the European Economic Area, persons who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (EU) 2017/1129 (as amended) and (b) in the United Kingdom, persons who are (a) "qualified investors", within the meaning of Article 2(e) of the Prospectus Regulation as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 who are also (i) investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); (ii) persons falling within Article 49(2)(a) to (d) of the Order (high net worth entities, unincorporated associations, etc.), or (iii) persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). Any investment or investment activity in the United Kingdom to which this announcement relates is only available to, and will be engaged only with, relevant persons. Any person in the United Kingdom who is not a relevant person should not act or rely on this announcement or any of its contents.
"Wolfe | Nomura Alliance" is the marketing name used by Wolfe Research Securities and Nomura Securities International, Inc. in connection with certain equity capital markets activities conducted jointly by the firms. Both Nomura Securities International, Inc. and WR Securities, LLC are serving as underwriters in this offering. In addition, WR Securities, LLC and certain of its affiliates may provide sales support services, investor feedback, investor education, and/or other independent equity research services in connection with this offering.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
VANCOUVER, BC / ACCESSWIRE / January 23, 2024 / Marvel Discovery Corp. (TSX-V:MARV)(Frankfurt:O4T)(OTCQB:MARVF); ("Marvel" or the "Company") is pleased to report that the Company has partly completed drilling operations on its Ni-Cu-Co and Ti-V-Cr Duhamel property (the "Property") located 350 kilometers (km) north of Quebec City, QC (Figure 1). The Company previously announced on December 04, 2023,that crews were being mobilized, but due to warmer temperatures an increase in water levels caused extreme flooding in nearby creeks and rivers causing the Company to pause drill operations before the Christmas season.
Figure 1: Regional location of the Duhamel Property
To date, three (3) drill holes have been completed (813m done for total of 1,200m) which are targeting numerous priority airborne and ground EM conductors within the Houlière block (figure 2). Historical work within the Property and surrounding areas have shown these conductors are the primary target horizons.
Figure 2: EM Anomaly Map of Houlier and Duhamel Blocks
Within the first target area, one historical hole drilled in 2000, within this 1km long x 400m wide target zone, intersected 0.64% Ni, 0.29% Cu and 0.06% Co over 4m (~2.56m true width) which included 0.90% Ni and 0.40% Cu and 0.08% over 2.66m (1.71m true width and also included 1.55% Ni, 0.31% Cu and 0.14% Co over 1.0 m (0.64 m t.w.) from hole 1279-00-01 (from 21.00 to 25.00 m).
The first hole drilled, DU24-01, intersected a wide, 28.6m, interval of disseminated mineralization from a hole depth 67.8m- 96.8m and within this are semi-massive stringers and massive sulphide zones ranging from widths of 15cm-60cm. An example of one of these massive sulfide bands with shows tremendous potential for nickel, copper, and cobalt mineralization intersected in drillhole DU24-01 is highlighted in figure 3.
Figure 3: Massive Sulphide Band Intersected in Hole DH24-01 (69.8m – 70.1m)
Duhamel Project
For general information, the Duhamel Property currently contains seven (7) occurrences of Ni-Cu-Co sulphides and one (1) Fe-Ti-V iron oxide occurrence discovered between 1997 to 2001 by previous operators who defined a 13 km long mineralized rock corridor (Figure 4). Drill intercept highlights include 1.27% Ni, 0.33% Cu, and 0.12% Co over 3.0 meters by Virginia Gold Mines in 2000 that contained massive sulfides. The recalculation of 100% sulfides from gave 2.42% Ni over 0.5m (hole 1279-2001-29 gave 1.4% Ni over 0.5m). Compilation of historic assessment reports to date reveals more than thirty (30) Ni-Cu (Co) and four (4) Fe-Ti (V, Cr) mineral occurrences which confirms this corridor to be highly prospective for new Ni-Cu-Co discoveries, as well as Fe-Ti (Cr, V) discoveries.
Further to the compilation of previously filed assessment reports Marvel recovered from historical data a grab sample (from massive Iron-Titanium Oxides), the result assaying 0.28% V2O5 associated with 20.8% TiO2 and 0.13% Cr203.
The Duhamel project is located between Chutes-des-Passes and Pipmuacan Reservoir deformation zones (or areas) included in central part of Proterozoic Grenville Geological Province (Figure 2). The Duhamel Property is characterized by the presence of large mafic to ultramafic intrusive rock bodies located in northern margin of the Saguenay‐Lac‐Saint‐Jean (SAGLSJ) Anorthosite Suite, one of the largest anorthosite intrusive bodies in the world. The Chute-des-Passes-Pipmuacan reservoir areas contains numerous massive sulfide and iron oxide mineralization occurrences recognized and documented by the Quebec government (Sigeom, Figure 3).
Figure 2. Cu-Ni-Co and Fe-V-Ti-Cr mineral occurrences in Houliere-Duhamel property (Modified from SIGEOM, 2023)
Karim Rayani, Chief Executive Officer, states, "Drilling results planned for late 2023 were delayed due to weather events, however we’re pleased with the progress made so early in 2024. All holes to date have intersected our target areas and to see these wide intervals of sulphide mineralization in our first drill-hole is a very good sign. There remains a plethora of Airborne anomalies to follow-up on this project, and we anticipate a very busy exploration season as we follow these up with low frequency TDEM surface surveys. Moving forward we are immediately planning low frequency BHEM surveys on all holes we drill, something never completed in any of the previous exploration campaigns. This will enable us to leave no rock unturned while giving us a greater chance of success by expanding our exploration radius. We remain bullish on Nickel and Copper prices as supply shortages loom, and demand returns as the push towards electrification and greening of our cities accelerates."
Qualified Person
The technical information contained in this report has been reviewed also by Jean-Paul Barrette Géo/ P.Geo, an independent project geologist and consultant. Mr. Barrette is a member of the Ordre des Géologues du Québec (OGQ, # 619). Mr. Barrette has sufficient experience (39 years) and relevant to the style of mineralization and the type of deposit under study and the activity undertaken to qualify as a competent person as defined by NATIONAL INSTRUMENT 43-101, Standards of Disclosure for Mineral Projects. Mr. Barrette carried out several geological reconnaissance works in the Houliere-Duhamel sector and recently made there a compilation of historical works.
About Marvel Discovery Corp.
Marvel, listed on the TSX Venture Exchange for over 25 years, is a Canadian based emerging resource company. The Company is systematically exploring its extensive property positions in:
Newfoundland, (Gander East, Gander South, Victoria Lake, and Hope Brook, Au- LiProspects.)
Atikokan, Ontario (BlackFly – Au Prospect)
Elliot Lake, Ontario (East Bull – Ni-Cu-PGE Prospect
Quebec (Duhamel –Ni-Cu-Co prospect & Titanium, Vanadium, and Chromium Prospect)
Prince George, British Columbia (Wicheeda North – Rare Earth Elements Prospect)
ON BEHALF OF THE BOARD Marvel Discovery Corp. "Karim Rayani" Karim Rayani President/Chief Executive Officer, Director Tel: (604) 716-1036 email: k@r7.capital
Disclaimer for Forward-Looking Information:
Certain statements in this release are forward-looking statements which reflect the expectations of management. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations, or intentions regarding the future. Actual future results may differ materially. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. There is no assurance any of the conditions for closing will be met. Forward-looking statements reflect the beliefs, opinions, and projections on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the respective parties, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Readers should not place undue reliance on the forward-looking statements and information contained in this news release concerning these times. Except as required by law, the Company does not assume any obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Unprecedented December storm damaged Shoreside Power System at the Port of Hueneme, causing more than $30M in damages
PORT HUENEME, CA / ACCESSWIRE / January 23, 2024 / The Port of Hueneme, the pioneering West Coast Port in adopting Shoreside Power for cargo vessels, faced substantial setbacks following severe damage to its Shoreside Power System during an unprecedented rain event on December 21 and 22, 2023.
Torrential rainfall, exceeding three inches per hour, impacted the City of Port of Hueneme and surrounding communities, leading to substantial damage and flooding to the Port’s Shoreside Power System-a 1,000-year storm event.
Throughout the 48-hour storm, Port crews worked tirelessly to pump water away from the system. However, the overwhelming force of water and converging stormwater flows from the local community and Naval Base Ventura exacerbated the situation, resulting in significant flooding. The Port, working in concert with Southern California Edison, promptly deactivated power to the shoreside power electrical infrastructure to ensure the safety of its staff, labor and the community.
Internal and external engineering teams including Schneider Electric, Southern California Edison, H3 Engineering and CAL-OES are conducting a thorough assessment. Projected costs to rebuild the system are upwards of $30 million to $40 million.
"The Shoreside Power technology first implemented by the Port of Hueneme in 2014 was a remarkable leap toward sustainability in the maritime industry," said Vahik Haddadian, CEO of H3 Engineering and technical expert for the Port. "The setback underscores the need for resilient infrastructure in the face of extreme weather events. I recommend the Shoreside Power be rebuilt to the highest standards required by the industry and for safety requirements."
Local 46 ILWU offered its support from the docks with more than 200 jobs filled at dispatch. Unionized trades also made a strong showing with representation from the Tri-Counties Labor Trades Council Local 46, IBEW, Plumbers and Pipefitters, Teamsters and LIUNA 585. "We must look at our history and how our Port has been critical to the growth of our community and great union jobs. When we received the call, we mobilized in an all-hands-on deck manner, and today we are here to stand by our Port" said Joshua Medrano, Executive Secretary of the Tri-County Labor Council.
The Port of Hueneme is fully committed to aggressively pursuing all available avenues and assistance to restore the Shoreside Power System. Collaborations with Ventura County Office of Emergency Services (VCOES), California Office of Emergency Services (CAL OES), and local, regional, state and federal authorities are underway to secure financial support for restoration efforts.
As a result of the damage, ocean going vessels will not be able to plug into Shoreside Power. The Port is closely monitoring air quality in collaboration with the Ventura County Air Pollution Control District and other environmental groups.
"This unforeseen challenge poses a significant impact on our community and operations," said Oxnard Harbor District Board President Celina Zacarias. "The collaboration between the Port, local authorities and community members is crucial as we work toward recovery and strengthening our resilience."
Despite this setback, the Port remains steadfast in its commitment to environmental sustainability, having been a pioneer in mitigating diesel emissions and will keep the course for zero emission targets for at berth vessels and all yard equipment by 2030.
In the short-term, the Port is exploring strategies to minimize impacts on operations, including the commission and purchase of an emissions capturing bonnet system and other innovative options. Long-term, the Port continues its dedication to pioneering technologies for decarbonization.
"Our commitment to environmental sustainability remains unwavering," said Port of Hueneme CEO Kristin Decas. "We appreciate the understanding and support from our community. With collective efforts, we are confident in overcoming this challenge and emerging stronger than before."
The event concluded with a symbolic demonstration of solidarity from Port officials, community leaders, and labor, all lining up in front of the damaged system to form a "powerwall," pledging to work together to secure funding and rebuild the Shoreside Power System.
For more than 80 years, the Port of Hueneme has been a cornerstone of economic activity in Ventura County, generating $2.8 billion in economic activity and supporting 24,997 trade-related jobs.
Flooded and Damaged Shoreside Power Infrastructure
Flooded and Damaged Shoreside Power Infrastructure
Parked Vehicles in Flooded Port Terminal
Outside of Shoreside Power System
Inside of Shoreside Power System
Port Officials, Community Leaders, and Labor Come Together in Solidarity
Oxnard Harbor District President Celina Zacarias and Commissioner Jason Hodge
About the Port of Hueneme The Port of Hueneme is one of the most productive and efficient commercial trade gateways for niche cargo on the West Coast. Five locally elected Port Commissioners govern the Port. The Port consistently ranks among the top ten U.S. ports for automobiles and fresh produce. Port operations support the community by bringing $2.8 billion in economic activity and creating 24,997 trade-related jobs. Trade through the Port of Hueneme generates more than $236 million in direct and related state and local taxes, which fund vital community services. In 2017, the Port of Hueneme became the first port in California to become Green Marine certified and was voted the Greenest Port in the U.S. at the Green Shipping Summit. www.portofh.org.
Press Contact Letitia Austin Public & Government Relations Manager laustin@portofh.org (805) 271-2205
DICKINSON, ND / ACCESSWIRE / January 23, 2024 / For the first time ever, scholars and the public will have the opportunity to delve into the rich legacy of Pulitzer Prize-winning historian Edmund Morris, through a collection of private research and memorabilia. The Morris Archives, recently acquired by the Theodore Roosevelt Presidential Library (TRPL), will be housed at the Theodore Roosevelt Center at Dickinson State University (DSU).
Over his lifetime, Morris’s scholarship transformed the way we think about the 26th president. The archive includes an extensive collection of notes, documents, audio and video tapes, photographs, and various personal ephemera and memorabilia, especially surrounding Morris’s well-known works such as Theodore Rex and The Rise of Theodore Roosevelt. This archive opens a window into not only Morris’s life but the rich treasures of Theodore Roosevelt’s life.
Through the generosity of Marc Brinkmeyer, owner and chairman of the board of the Idaho Forest Group, and his wife, Vicki, we can learn how this great biographer came to be. Marc explains, "Vicki and I were enthusiastic to be able to serve as the enablers to place this important repository into the Theodore Roosevelt Presidential Library. It allows the Morris literary achievements to endure and will serve as a foundation for the Library’s mission and continuing Roosevelt scholarship."
While the volume of the collection is quite expansive, the significance is even more impactful. Morris kept exacting records of his work and personal reflections on the men he profiled. The collection also includes the papers of Sylvia Jukes Morris, his wife and literary equal who wrote biographies of First Lady Edith Kermit Roosevelt and Congresswoman Clare Booth Luce.
"A complete analysis of Theodore Roosevelt’s life is not possible without consulting Edmund Morris. As such, our presidential library would not be complete without Edmund Morris’ archives. With this addition, this project’s commitment to scholarship and historical analysis is brought to new heights," said Edward F. O’Keefe, CEO of TRPL. "The Morris Archives stand as a testament to the enduring legacy of Theodore Roosevelt, and we are incredibly grateful to Marc and Vicki Brinkmeyer and Dickinson State University for making this possible."
About TRPL: The Theodore Roosevelt Presidential Library is being built in Medora, North Dakota, and is expected to open on July 4, 2026, the 250th anniversary of America. This will be a library and museum truly like no other. Designed by the international architectural firm Snøhetta, the Theodore Roosevelt Presidential Library will be the only carbon-neutral presidential library and will function in harmony with the unique ecology that surrounds it, being a model of self-sufficiency.
According to KeyBank’s annual Financial Mobility Survey, Americans are prioritizing happiness over status and achievement but remain concerned about the financial year ahead
CLEVELAND, OH / ACCESSWIRE / January 23, 2024 / The KeyBank 2024 Financial Mobility Survey finds that a resounding 66% of Americans would rather work a job they love with a lower paying salary than work a job they hate with a higher paying salary (34%). Simultaneously, a quarter of Americans say they’re spending more and saving less, up from years prior (15% in 2022 and 13% in 2021), and 60% believe we are in or will soon be in a recession-pointing to an environment in which Americans are prioritizing happiness while bracing for economic challenges.
In fact, nearly one third (30%) of survey respondents say they feel daily financial stress related to the cost of living in America, and more than half (59%) are cutting back on nonessential items due to the increasing cost of living. To add, more people would rather share their recent Google search history (57%) than their monthly credit card statement (43%). Still, when asked what ‘Thriving in America’ means to them, 42% chose work life balance.
The survey polled more than 1,000 Americans on their financial, life and work-related priorities and outlook after a year of market volatility and uncertainty. To learn more about the survey’s findings, review the KeyBank 2024 Financial Mobility Survey Executive Summary here.
"We all want to feel fulfilled, and our survey shows that Americans are prioritizing their happiness and personal life over money-but facing inflation, societal shifts and economic uncertainty, many remain concerned about their financial futures," said Daniel Brown, EVP & Director, Consumer Product Management at KeyBank. "As the everyday cost of living increases, many of us will have to make critical lifestyle and financial decisions in the year ahead for not only ourselves, but also our households-balancing our lives outside of work with our financial needs and habits for the long term."
As Americans focus on their personal well-being, many are in favor of a "soft-life culture" that defines success based on happiness, contentment, and fulfillment vs. "hustle culture," which defines success based on wealth, status, and achievement (36% and 28% respectively). Yet, 56% of Gen Z respondents say they currently identify most with a hustle culture-highlighting a generational gap in experiences and priorities.
Highlights include:
Work-life balance is increasingly important. Continuing a trend seen year over year, more Americans say they value work-life balance (63%) over a high-paying salary (27%), compared to 57% and 33% respectively in 2022.
Half (51%) of Americans have pulled more money from their savings this year than before. More than three in four (77%) of respondents across all generations believe the cost of living in America has gotten worse, with Boomers leading that feeling (92%).
Millennials and Gen Xers are more likely to anticipate a recession in 2024. Of respondents that expect to be in a recession in the next 12 months, more than half (57%) are Millennials or Gen X.
Women (35%) are more likely than men (24%) to feel financial stress related to the cost of living in American on a daily basis.
Americans are making financial changes to achieve the dream of homeownership. Of those who are in the market for a home, the top step taken to save money for a home is to put away money in a dedicated savings account (43%). Still, 29% of Americans do not own a home and do not plan on purchasing one in the next 12 months. Of those respondents, only 1 in 10 indicate that home ownership is very attainable.
As Americans increasingly aim to strike a balance between professional success, personal fulfillment, and overall financial well-being, KeyBank is here to support them on their journeys. Consumers can access online resources designed to enhance financial confidence and savvy, from the Financial Wellness Center‘s Banking 101 curriculum, to the option to schedule a Financial Wellness Review to better understand your financial situation and chart the best path forward.
Methodology
This survey was conducted online by Schmidt Market Research. 1,000 Americans, ages 18-70, with sole or shared responsibility for household financial decisions, who own a checking or savings account, completed the survey in September 2023. The survey asked respondents about their financial attitudes, understanding, awareness and actions over the prior year.
About KeyCorp
KeyCorp’s (NYSE: KEY) roots trace back nearly 200 years to Albany, New York. Headquartered in Cleveland, Ohio, Key is one of the nation’s largest bank-based financial services companies, with assets of approximately $188 billion at December 31, 2023.
Key provides deposit, lending, cash management, and investment services to individuals and businesses in 15 states under the name KeyBank National Association through a network of approximately 1,000 branches and approximately 1,200 ATMs. Key also provides a broad range of sophisticated corporate and investment banking products, such as merger and acquisition advice, public and private debt and equity, syndications and derivatives to middle market companies in selected industries throughout the United States under the KeyBanc Capital Markets trade name. For more information, visit https://www.key.com/. KeyBank is Member FDIC.
SHANGHAI, CHINA / ACCESSWIRE / January 23, 2024 / Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) has been named by the Top Employers Institute as a Top Employer China for the sixth consecutive year. Ranked fourth overall among more than 150 companies included in the list, Yum China again placed first in the restaurant industry. This accolade highlights the Company’s outstanding performance in key areas such as People Strategy, Digital HR, Working Environment and Career Development. It also reflects Yum China’s "People First" philosophy and commitment to providing an excellent working environment and experience for its employees.
"To be named a Top Employer China for six consecutive years is a testament to our unwavering commitment to our people," said Joey Wat, CEO of Yum China. "At the heart of our success lies our ‘Fair, Care, and Pride’ principle, which includes nurturing a vibrant and inclusive culture that supports our team members’ growth and our company’s progress."
Jerry Ding, Chief People Officer of Yum China, said, "With a diverse team of over 400,000 people, our employees are the cornerstone of the company’s growth and resilience. Our talent strategy, centered on a vision of healthy and sustainable growth, is significantly enhanced by our embrace of technological innovation. This strategy deepens our dedication to employee care, reinforcing Yum China’s position as a leader in the restaurant industry."
Yum China is committed to fostering a diverse, inclusive and non-discriminatory working environment, enabling its people to unleash their potential regardless of their gender or background. By end of 2023, female employees represented more than 50% of the Company’s total workforce. The Company also prides itself on being at the forefront of the industry in ensuring fair and competitive compensation and benefits. This includes providing an equity incentive plan for Restaurant General Managers (RGMs), allowing them to share in the company’s growth and success. Since its inception in 2016, the program has awarded Restricted Stock Units (RSUs) to over 13,000 RGMs. In addition, the Company’s comprehensive "YUMC Care" benefit plan offers tailored benefits according to life stage and individual needs.
Yum China’s suite of learning and development programs actively support the career development and growth of employees. Key initiatives include structured career advancement opportunities for restaurant operations team members and specialized training for marketing and supply chain management trainees. In 2023, the Company launched its "Yum China Bytes & Bites Program" to offer working opportunities to approximately 80 students from leading Chinese universities at Yum China’s Digital Research Centers, integrating cutting-edge technology with practical industry experience. Yum China also provides a supportive and inclusive environment for employees with special needs through its "Angel Restaurants" initiative. As of the end of June 2023, KFC China has 46 "Angel Restaurants" in 42 cities, employing over 200 individuals with special needs.
Embracing new technologies remains a key factor underpinning Yum China’s recognition as a Top Employer China. As a pioneer in digital transformation, the Company has leveraged AI to optimize demand forecasting, inventory management, crew scheduling, and production to empower frontline managers, while helping to promote more sustainable business growth.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the Company’s business strategy and capital allocation strategy. We intend all forward-looking statements to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the fact that they do not relate strictly to historical or current facts and by the use of forward-looking words such as "goal," "expect," "expectation," "believe," "anticipate," "may," "could," "intend," "belief," "plan," "estimate," "target," "predict," "project," "likely," "will," "continue," "should" or similar terminology. These statements are based on current estimates and assumptions made by us in light of our experience and perception of historical trends, current conditions and expected future developments, as well as other factors that we believe are appropriate and reasonable under the circumstances, but there can be no assurance that such estimates and assumptions will prove to be correct. Forward-looking statements are not guarantees of performance and are inherently subject to known and unknown risks and uncertainties that are difficult to predict and could cause our actual results or events to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or assumptions will be achieved. The forward-looking statements included in this press release are only made as of the date of this press release, and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. Numerous factors could cause our actual results or events to differ materially from those expressed or implied by forward- looking statements. In addition, other risks and uncertainties not presently known to us or that we currently believe to be immaterial could affect the accuracy of any such forward-looking statements. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. You should consult our filings with the SEC (including the information set forth under the captions "Risk Factors" and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q) for additional detail about factors that could affect our financial and other results.
About Yum China Holdings, Inc.
Yum China is the largest restaurant company in China with a mission to make every life taste beautiful. The Company has over 400,000 employees and operates over 14,000 restaurants under six brands across 1,900 cities in China. KFC and Pizza Hut are the leading brands in the quick-service and casual dining restaurant spaces in China, respectively. Taco Bell offers innovative Mexican-inspired food. Yum China has also partnered with Lavazza to develop the Lavazza coffee concept in China. Little Sheep and Huang Ji Huang specialize in Chinese cuisine. Yum China has a world-class, digitalized supply chain which includes an extensive network of logistics centers nationwide and an in-house supply chain management system. Its strong digital capabilities and loyalty program enable the Company to reach customers faster and serve them better. Yum China is a Fortune 500 company with the vision to be the world’s most innovative pioneer in the restaurant industry. For more information, please visit http://ir.yumchina.com.
Jerry Ding, Chief People Officer of Yum China, accompanied by six Restaurant General Managers (RGMs), accept the Top Employer China award on behalf of the company.
OTC availability as an erectile dysfunction treatment medication furthers interest in a topical alternative to Viagra and Cialis.
VICTORIA, BC / ACCESSWIRE / January 23, 2024 / Few, if any, new OTC medications have arrived on the market and generated as much interest as Eroxon has for men with erectile dysfunction. Eroxon has a different mechanism of action from oral ED drugs: it is a gel that is applied topically onto the skin. It is now available from Canada Drugs Direct and other Canadian online pharmacies that dispense medication for less.
Canada Drugs Direct logo
The buzz about Eroxon is that it is applied topically and works quickly, with claims that it will take effect within 10 minutes of application for most men. Eroxon, a topical gel, uses an evaporative effect to increase nitric oxide production, thereby enhancing the relaxation of smooth muscle tissue.
Another aspect of Eroxon’s growing appeal is that it can be purchased without a prescription due to being an over-the-counter (OTC) medication. In June of last year, the US FDA approved Eroxon. Men who find it effective may opt to continue using Eroxon instead of oral ED medications. For these individuals, ordering it in bulk from an online pharmacy might be a practical option.
Another aspect of Eroxon’s growing appeal is that it can be purchased without a prescription. Being an over-the-counter (OTC) medication means it is increasingly accessible, and a growing number of men are inquiring whether they can obtain Eroxon at pharmacies or drugstores near their homes. In June of last year, the US FDA approved Eroxon. Men who find it effective may opt to continue using Eroxon instead of oral ED medications. For these individuals, ordering it in bulk from an online pharmacy might be a practical option.
The trend of US residents ordering medications from Canada to save money is not new. It is highly likely that the lower prices of Eroxon at Canadian online pharmacies will lead men to order Eroxon from Canada for the same reason. Men seeking an ED treatment that is readily accessible, and in non-pill form, can obtain Eroxon from Canada Drugs Direct.
About the Company
Canada Drugs Direct, a Canadian online pharmacy, is recommended for Americans looking to save money on medications by shopping at a Canadian pharmacy. Canada Drugs Direct sources medications in a manner that ensures competitive pricing on Canadian prescription drugs. Like any American pharmacy, all orders require a prescription and are dispensed by a licensed pharmacist. Save on prescription medications ordered online from Canada.
CHICAGO, IL / ACCESSWIRE / January 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has successfully completed the acquisition of Cloudscreen®, a cutting-edge Artificial Intelligence (AI) powered platform. The acquisition is pursuant to the purchase agreement announced on October 11, 2023.
Cloudscreen is a multimodal platform specialized in drug repurposing, a process that involves uncovering new target proteins or indications for existing drugs for use in treating different diseases. The platform focuses on identifying new therapeutic uses for drugs that have already been tested for safety and efficacy. This approach also includes the exploration of abandoned drugs for potential application in treating different diseases, thereby broadening the scope of possibilities in finding effective treatments through repurposed pharmaceuticals.
Cloudscreen integrates 1D and 3D data into an AI algorithm, which comprehensively interrogates the druggable proteome (the complete set of proteins) and variome (the whole set of genetic variations), to provide accurate predictions for existing drugs towards new indications. The platform is complemented with real time in vitro validation towards effectiveness and toxicity predictions.
Cloudscreen Engine: Drug repositioning AI algorithm based on 3D & 1D structural information of drug targets
Repurposed discoveries offer several advantages compared to traditional drug development, including higher success rates of 1/10 versus 1/1000 for traditional discovery. Additionally, these discoveries benefit from heightened safety profiles and significantly shorter impact times, ranging from 2-5 years as opposed to the 10-15 years in traditional drug development, all while being substantially more cost-effective, with expenses of around $5 million on average compared to over $1.5 billion on average in traditional methods.
Cloudscreen is committed to disrupting the field of drug repurposing by addressing the significant limitations of current methodologies. Traditional approaches in this domain have predominantly relied on textual data and faced the challenge of limited protein structural information, covering only about 20% of the Proteome. This often results in contradictory information within the extensive big data sets. Cloudscreen’s strategy involves the integration of 3D structural information to provide a more accurate molecular level focus, transcending the limitations of textual data. The company is also dedicated to expanding its database to include 100% of the Proteome space, thereby filling a critical gap in protein structural information. Additionally, Cloudscreen employs advanced Machine Learning (ML) algorithms to enhance the reliability and confidence in its predictive models, offering a more sophisticated and dependable solution in drug repurposing.
From 2024 to 2029, Cloudscreen is strategically focusing on developing repurposed drugs in five key therapeutic areas: obesity, rare diseases, infectious diseases, cancer, and autoimmune diseases. This ambitious initiative will be executed through a series of meticulously planned steps. It begins with simultaneous platform upgrades and active pharmaceutical ingredients (APIs) selection during 2024-2025, with API selection extending into 2026. In parallel, from 2024 to 2028, the development and utilization of AI-powered predictions will play a crucial role in identifying potential drug repurposing opportunities in these specific areas. To ensure the validity and applicability of these AI insights, expert validation will be conducted concurrently until 2029. This phase will be complemented by experimental validation from 2025 to 2029, where the theoretical predictions will be tested in practical scenarios. The final step in this comprehensive process is the preparation and filing of patents from 2025 to 2029, securing the intellectual property rights for the innovative therapeutic uses discovered. This holistic approach integrates advanced technology and expert knowledge to revolutionize drug repurposing in these critical areas of healthcare.
The global drug repurposing market is experiencing significant growth, with MarketWatch projecting its value to reach $30.6 billion by 2028, of which $10 billion relates to the EU market. This growth is being fueled by advances in computational power and the emergence of new approaches such as AI and Machine Learning, which are enabling more cost-effective solutions for drug repurposing. In the U.S. drug discovery market, ΑΙ is most commonly applied for drug optimization and repurposing, as depicted in the accompanying graph.
Cloudscreen’s founders and its senior scientific team will continue to lead the research and execution of new drug repurposing projects. Each project has the potential to lead to patent filing upon successful completion of the in vitro validation.
Greg Siokas, Chief Executive Officer of Cosmos Health, stated: "Today marks another significant milestone in our ongoing transformation into a full-fledged pharmaceutical company. Drug repurposing has emerged as a key strategy for pharmaceutical companies to fuel innovation and growth. Through the acquisition of Cloudscreen, Cosmos is not just investing in drug repurposing but also, in particular, in its AI-powered applications. This strategic move positions Cosmos to potentially capture a larger share of the lucrative multi-billion dollar global drug repurposing market.
"Cloudscreen has already demonstrated impressive results. For instance, we recently announced the acquisition of rights arising from a patent for addressing certain central nervous system (CNS) cancers. This patent was made possible by Cloudscreen’s AI drug repurposing platform. We anticipate carrying out multiple repurposing projects over the coming years.
"Moreover, sharing their confidence in our vision, as well as our belief that our share price is undervalued, Cloudscreen’s founders have agreed to accept Cosmos stock at a price well above the current share price. Going forward, we plan to capitalize on Cloudscreen’s momentum, which will further advance and accelerate our ambitious R&D aspirations. This brings us closer to our goal of spinning off our R&D division into a standalone, publicly listed biotech company, which we believe will unlock significant value for our shareholders. Overall, this represents a transformative moment for Cosmos that introduces a new dimension and source of value."
About Cosmos Health Inc.
Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Chicago, Illinois, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe® and C-Sept®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency, it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com, www.skypremiumlife.com, www.cana.gr, and www.zipdoctor.co, as well as LinkedIn and X.
Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could", are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company’s ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic and the war in Ukraine, on the Company’s business, operations and the economy in general, and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
Paul Lampoutis Capital Link, Inc. 230 Park Avenue, Suite 1540 New York, N.Y. 10169 Tel.: (212) 661-7566 Fax: (212) 661-7526 E-Mail: Cosmoshealth@capitallink.com
Non-prescription gel goes on topically to counter erectile dysfunction and is an OTC alternative to Viagra.
VICTORIA, BC / ACCESSWIRE / January 23, 2024 / As an OTC alternative to Viagra and Cialis, Eroxon was US FDA-approved on June 13, 2023, and is available from both storefront and online pharmacies, including Canada Pharmacy and others in Canada, which can offer a lower price on Eroxon.
Canada Pharmacy Logo
Eroxon, which comes in single-dose tubes of gel, is also expected to be a comparatively affordable erectile dysfunction treatment. Eroxon received approval in the European Union as a Class 2B medical device in April 2021.
Eroxon is a topical gel with a different mechanism of action compared to these other ED treatment meds. It works with a combination of solvents that evaporate quickly to promote a cooling-to-warming effect, resulting in more nitric oxide relaxing smooth muscle tissue. This enhances blood flow, and it is claimed that Eroxon will take effect within 10 minutes of application.
US residents are increasingly having prescriptions filled in Canada because of the lower costs for prescription medications. This also applies to OTC products, including Eroxon, as it is becoming more available in America.
About the Company
Canada Pharmacy is a Canadian online pharmacy among those recommended for Americans who shop at a pharmacy in Canada to save money on medications. It can source medications in a way that allows for the best prices on prescription drugs from Canada. All orders require a prescription and are dispensed by a licensed pharmacist, in the same way as it would be with any pharmacy in America. Pay less when you order drugs online from Canada.
PLEASANT GROVE, UT / ACCESSWIRE / January 23, 2024 / NLC Insurance® announces the continued expansion of the IMGING® property inspection data platform by Loveland Innovations to enhance customer experience during property claims. By incorporating IMGING’s inspection and property data analytical tools, adjusters work claims faster and more accurately, improving the overall claims experience.
Loveland Innovations Logo
Now in year three of this partnership, NLC is expanding usage to their entire claims organization, providing NLC property claims adjusters with IMGING’s AI-powered inspection platform. By centralizing property inspection data in one platform, NLC will gain further efficiency and consistency in claims management.
"Our goal is to continually improve the quality and speed of our claims handling to deliver an excellent experience for our customers," said Richard Lord, VP of Claims at NLC Insurance Companies. "IMGING helps us do that. Performing inspections safely, measuring roofs, and managing property data are simple, fast, and accurate in the IMGING platform. This removes manual tasks from our adjusters’ workload, allowing them to handle more claims while staying laser-focused on the customer experience."
"NLC’s reputation of providing a supportive, personal, and local insurance is evident in their commitment to ever improving the claims management process," said Jim Loveland, Founder and CEO of Loveland Innovations. "Their focus on providing an excellent customer experience makes it a pleasure to work together."
Loveland Innovations’ IMGING®, is an AI-powered property data and inspection platform that serves as a centralized hub of analysis and capture for all claims data. It automates and makes consistent data capture easy with patented technology, provides precise 3-D models and measurements, organizes photos to custom specifications in the cloud, uses automated artificial intelligence to identify potential damage for adjuster review, and makes reporting, sharing, and collaboration simple.
About NLC Insurance
Founded in 1840 in Norwich, Connecticut, NLC Insurance has over 190 years of insurance expertise, serving most New England states with a focus on homeowners, auto, dwelling fire, and commercial policies. We work with 300+ independent agencies and are proud members of industry associations, including the National Association of Mutual Insurance Companies and the Property Casualty Insurance Association of America. NLC’s enduring legacy and dedication ensure reliable insurance for years to come.
About Loveland Innovations
Loveland Innovations is the maker of IMGING, the leading platform for property inspections and analytics. With IMGING, inspection professionals use smartphones and automated drones to digitize a property or structure, and analyze it with the help of deep learning and computer vision, giving them the clarity to act quickly and confidently.
MIAMI, FL / ACCESSWIRE / January 23, 2024 / Alerium Nutrition, a nutritional brand, has announced the launch of their first three products for purchase: Primal Fire, a male support formula; Miracle Brain, a nootropic formula; and Real Biome, a probiotic. This release signifies the true launch of the company, which was initially founded in 2023.
Alerium’s first three products: Primal Fire, Miracle Brain, and Real Biome
Alerium is a new brand that focuses on providing high quality, dietary products. Their offerings are science-backed, third-party tested for purity, and formulated by a board of PhDs. The company’s founders wanted to craft a state-of-the-art product line based on science and free of unnecessary and hidden additives. They seek to avoid proprietary blends, a technique commonly used to hide ingredients and dosages.
The brand was created last year based on the pillars of quality, efficacy, and transparency. The team strives to keep customers in mind first and foremost, and the company’s mission is to serve and try to inspire anyone seeking to step into a new paradigm of health.
Alerium Nutrition’s new products are intended for both men and women between the ages of 25 and 55, with the goal of promoting a higher level of health by offering nutritional products that can be easily taken at home on a daily basis. For those who don’t have the means or time to focus on their health above other priorities, Alerium hopes to provide an effective solution to certain ailments.
Their initial product line is officially available for purchase. The first supplement, Primal Fire, is a male support formula that blends four natural herbs that have been tested in placebo-controlled, human clinical trials to support testosterone production, stamina, overall energy, and physical recovery.
Miracle Brain is a nootropic formula designed to provide mental clarity for day-to-day activities. It contains an ingredient called Affron, a patented form of saffron extract which has the potential to improve mood levels in adults. Miracle Brain can help support sustained focus and stability for a demanding routine, while also healing and protecting the brain long-term.
Their final new product, Real Biome, is a probiotic designed to survive stomach acidity and thrive inside the intestines. The company paired its symbiotic strain with a powerful pre-biotic that allows the active bacteria to flourish and multiply inside the gut, which has the potential to provide multiple benefits to immune health and ease bloating and stomach problems. It is safe for daily use and recommended for use with post-antibiotic regimens.
The team at Alerium Nutrition believes in the importance of providing transparent, additive-free formulas for all of their supplements. They feel that their audience is made up of health conscious, socially active, and inquisitive individuals who see the importance of clean formulas.
In the coming months, the Alerium Nutrition team hopes to continue working on broadening their product base to provide customers with more options for health-driven supplements.
About Alerium Nutrition
Alerium Nutrition is a nutritional brand that offers products designed to target different health goals. Each product is tested for purity and formulated by a board of PhDs whose focus is to eliminate additives and prioritize natural ingredients.
Disclaimer: These statements have not been evaluated by The Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
LONDON, UK / ACCESSWIRE / January 23, 2024 / NFG Sarl ("NFG"), a global diversified private investment holding company announced today that its subsidiary, NFG Partners SA ("NFG Partners") has entered into an agreement to acquire a minority equity stake in Zodiac Partners Ltd. ("Zodiac"), a United Kingdom based securities broker and wealth manager. This strategic investment marks a significant milestone for both companies and sets the stage for a synergistic partnership that will enrich their product offerings and elevate the overall client experience.
The collaboration aims to take advantage of the recent financial services trade deal between Switzerland and the UK. By leveraging their combined, services, expertise, and market insights, the two firms aim to create a strategic alliance that will redefine the landscape of wealth management for their respective clients.
Zodiac, founded in 2017 by Christopher Panayiotou and Wayne Davis CFA, specializes in providing trading, pension fund management and institutional dealing creating a one stop investment house for the professional investor.
NFG Partners is a Geneva-based asset and wealth management firm regulated by FINMA servicing corporate, family offices, UNWI and institutional clients including its parent, NFG.
The agreement allows NFG Partners to increase its equity stake over time subject to regulatory approvals. As part of the agreement, in addition to providing working and expansion capital, Mr. Zameer Manji, Managing Director of NFG Partners, shall join the board of Zodiac Partners and a new Chief Legal Officer and Chief Operating Officer have been identified, and shall be appointed following regulatory approval, further strengthening the Zodiac team, from a legal, compliance and operational perspective.
Mr. Manji expressed enthusiasm about the collaboration, stating, "This strategic investment aligns perfectly with our vision for growth and commitment to delivering exceptional value to our clients. We are excited about the opportunities that this partnership brings and believe that it will further strengthen our position in the wealth management industry."
Mr. Wayne Davis, Co-Founder of Zodiac, added, "We are pleased to welcome NFG Partners SA as a strategic investor. This tie-up in particular enhances our discretionary management offering, benefitting from their systematic investment approach. By joining forces, we are well-positioned to offer an even more comprehensive suite of services to our clients."
The conclusion of the overall transaction is subject to FCA regulatory approvals and customary closing conditions.
About NFG Sarl
NFG Sarl, is a global diversified private investment holding firm which operates across multiple business units including insurance, reinsurance, insurance services, specialty risk and finance, asset management, energy, infrastructure, trade finance and banking with operations located throughout Europe, United States, the Caribbean, Asia and Africa. For more information, please visit our website at: www.nfgsarl.ch
About NFG Partners SA
NFG Partners SA is a Geneva based wealth and asset management firm providing bespoke discretionary and non-discretionary portfolio management and advisory services to a global client base including family offices, companies, institutions, and UNWI. NFG Partners is regulated by the Swiss Financial Market Supervisory Authority (FINMA). For more information, please visit our website at: www.nfgpartners.ch
About Zodiac Partners Ltd.
Zodiac Partners Ltd is a UK-based securities broker and wealth manager dedicated to providing tailored financial solutions and personalised services to its clients. With a reputation for excellence and a client-centric approach, Zodiac is poised for sustained growth and innovation in the wealth management and CFD industry. Zodiac is authorized and regulated by the Financial Conduct Authority FRN 806702. For more information, please visit our website at: www.zodiacpartners.co.uk
